A detailed history of Planning Capital Management Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 14,757 shares of IBRX stock, worth $74,375. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,757
Previous 14,757 -0.0%
Holding current value
$74,375
Previous $93.3 Million 41.14%
% of portfolio
0.04%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.82 - $9.15 $6,820 - $12,947
1,415 Added 10.61%
14,757 $93.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $5.21 $16,677 - $69,511
13,342 New
13,342 $67 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $2.02B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.